Bloomberg Talks podcast

Eli Lilly CFO Lucas Montarce Talks Weight Loss Pill, Business Outlook

0:00
9:08
Rewind 15 seconds
Fast Forward 15 seconds

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

See omnystudio.com/listener for privacy information.

More episodes from "Bloomberg Talks"